A 51% reduction in peanut allergy prevalence was observed but did not reach statistical significance in the intention‐to‐treat (ITT) analysis. 6 Adherence to peanut consumption in the LEAP study was 92%.
← all excerpts
Early introduction of peanut reduces peanut allergy across risk groups in pooled and causal inference analyses.
1
—
—